FTO enhances the proliferative capacity of GC cells and induces mitochondrial fusion by promoting the expression of CDKAL1, ultimately leading to the resistance of GC cells to chemotherapy (Liu Y. et al., 2023). This evidence concerns the gene CDKAL1 and gastric cancer.